Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Precision BioSciences Secures $13M From Imugene Convertible Note Maturity As Part of Azer-cel Deal

Author: Benzinga Newsdesk | September 03, 2024 07:27am

-- Payment includes $9.75 million cash and $3.25 million in Imugene Limited ordinary shares--

--The addition of this cash further reinforces Precision's expected cash runway into the second half of 2026--

Posted In: DTIL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist